We’re happy to publish the Application Note concerning the research carried out by our team at the Pharmaceutical Testing Laboratory in Utrecht, in conjunction with colleagues at the STERIS Gamma Sterilisation site in Ede, NL and the Bruker research lab in Bremen, on irradiated Oxybutynine
Details
The recent combination of STERIS Corporation and Synergy Health has created a leading global service supplier, providing Customers with a network of over 50 contract sterilization and laboratory facilities worldwide. As a combined organization, STERIS Applied Sterilization Technologies (AST) is committed to providing both global and local Customers with processing capacity through various technologies worldwide.
Details
On Tuesday 8th March Synergy Health, now part of STERIS team celebrated the opening of their brand new microbiological laboratory in Radeberg, Germany. This adds to the current network of STERIS Pharmaceutical Laboratories in the UK, Ireland, Netherlands, Italy and Czech Republic.
Details
Significant progress has been made to the warehouse extension project at our AST facility in Radeberg, Germany and we are very pleased to announce that it was completed at the end of 2015. The expansion project began in 2014 and will provide over 750 additional storage spaces for the Gamma and E-beam irradiation facility.
Details
STERIS plc (NYSE: STE) (“STERIS”) announced today that it has completed the previously announced combination of STERIS Corporation and Synergy Health plc (“Synergy”). As a result of the transaction, STERIS Corporation and Synergy are now combined under STERIS.
Details
STERIS Applied Sterilization Technologies is pleased to announce the expansion of its existing Temecula, California ethylene oxide sterilization facility to include small volume processing. The expansion will add four small ethylene oxide chambers of various sizes to the existing medium-sized chambers already in use at the Temecula facility.
Details